No Effect of an Automated Bolus Calculator in Pediatric Patients with Type 1 Diabetes on Multiple Daily Injections: The Expert Kids Study

Diabetes Technology&Therapeutics,Volume 21, Issue 6, Page 322-328, June 2019.
Source: Diabetes Technology - Category: Endocrinology Authors: Source Type: research

Related Links:

Publication date: December 2019Source: Biomedicine &Pharmacotherapy, Volume 120Author(s): Eman A. Abd El-Ghffar, Nesrine M. Hegazi, Hamada H. Saad, Mohamed M. Soliman, Mohamed A. El-Raey, Safia M. Shehata, Alaa Barakat, Aziz Yasri, Mansour SobehAbstractThe phenolic profile of the leaves of Beta vulgaris subspecies vulgaris variety rubra was investigated by high-performance liquid chromatography (HPLC) coupled to electrospray ionization high resolution mass spectrometric (ESI-HRMS-MS) detection. Mass spectrometry-based molecular networking was employed to dereplicate the known compounds. Twelve known compounds, seven of...
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
Condition:   Insulin-Dependent Diabetes Mellitus 1 Interventions:   Other: High GI calculated by CC (CHGI);   Other: Low GI calculated by CC (CLGI);   Other: High GI calculated by FII (FHGI);   Other: Low GI calculated by FII (FLGI) Sponsor:   TC Erciyes University Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
New J. Chem., 2019, Accepted Manuscript DOI: 10.1039/C9NJ02460C, PaperSamuel Trevi ño, Enrique Gonzalez-Vergara Diabetes mellitus is a pandemic expected to spread from 422 million patients in 2014 to 592 million patients in 2035. Type 1 diabetes mellitus (T1D) is characterized by both autoimmune... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - New J. Chem. latest articles - Category: Chemistry Authors: Source Type: research
In this study, AT1-AAs were detected in the sera of patients with peripheral arterial disease (PAD) and the positive rate was 44.44% vs. 17.46% in non-PAD volunteers. In addition, analysis showed that AT1-AAs level was positively correlated with PAD. To reveal the causal relationship between AT1-AAs and vascular aging, an AT1-AAs-positive rat model was established by active immunization. The carotid pulse wave velocity was higher, and the aortic endothelium-dependent vasodilatation was attenuated significantly in the immunized rats. Morphological staining showed thickening of the aortic wall. Histological examination showe...
Source: Fight Aging! - Category: Research Authors: Tags: Medicine, Biotech, Research Source Type: blogs
THURSDAY, Oct. 17, 2019 -- Patients with type 1 diabetes using an artificial pancreas or closed-loop system spend a greater percentage of time in a target glycemic range compared with those using a sensor-augmented insulin pump, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
We ’ve all read about the potential for data to transform healthcare by enabling patients to better understand their conditions and engage better in their treatment.  Now a handful of pioneers are starting to demonstrate the potential and to justify some of the hype. Some rapid improvements in outcomes and adherence point the way to a future in which agile pharma teams routinely work with ever more real-time, real-world data to rapidly and iteratively improve patient insights and outcomes. In the era in which payments will increasingly be tied to results, such innovations should be of huge value, and w...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news
First 6-month study with control group shows investigational closed-loop insulin delivery system improves time-in-range for patients with type 1 diabetes. But such systems are still far from perfect.Medscape Medical News
Source: Medscape Pediatrics Headlines - Category: Pediatrics Tags: Diabetes & Endocrinology News Source Type: news
A Minnesota woman with type 1 diabetes has launched a new small business, Blue Circle Art Therapy, to help people cope through creativity.
Source: Diabetes Mine - Category: Endocrinology Authors: Source Type: blogs
by Andreas Ochs, Stuart McGurnaghan, Mike W. Black, Graham P. Leese, Sam Philip, Naveed Sattar, Caroline Styles, Sarah H. Wild, Paul M. McKeigue, Helen M. Colhoun, on behalf of the Scottish Diabetes Research Network Epidemiology Group and the Diabetic Retinopathy Screening Collaborative BackgroundNational guidelines in most countries set screening intervals for diabetic retinopathy (DR) that are insufficiently informed by contemporary incidence rates. This has unspecified implications for interval disease risks (IDs) of referable DR, disparities in ID between groups or individuals, time spent in referable state before scre...
Source: PLoS Medicine - Category: Internal Medicine Authors: Source Type: research
NIH-funded study of people with type 1 diabetes shows safety, efficacy benefits of new system.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: Children | Diabetes | Diabetes Type 1 | Endocrinology | Pediatrics | Study